In the competition for This year’s Innovation appointed by PwC and Lund Innovation Systems, Malin Lindstedt and Anki Malmborg Hager at SenzaGen gets the Honorary Prize and is awarded 50.000 […]
SenzaGen har precis genomfört en riktad nyemission för att accelerera bolagets snabbt växande omsättning, skala upp försäljningsorganisationen, slutföra pågående validerings-processer och utveckla nya tester i GARD-portföljen. Intresset har varit överväldigande […]
Anki Malmborg and SenzaGen is one of the two winners of the region final of Sweden’s biggest innovation prize, the SKAPA Prize. The winner of this development prize and the […]
SenzaGen has won yet another award and was recently appointed the provincial finalist in Skåne and will thereby have the opportunity to win the national innovation award SKAPA, the country’s […]
SenzaGen AB, a diagnostic spin-off company from Lund University, is proud to announce that Prof. Ian Kimber will join the Board of Directors. SenzaGen AB is a diagnostic company working […]
– The investment will be used to sharpen Senzagen business model and develop software linked to cell-based in vitro assays, says Anki Malmborg Hager, CEO at SenzaGen. Press reslease at […]
SenzaGen one of the five most praised companies at Ny Teknik & Affärsvärldens big Inovation Event for the 33 most promising young innovativ companies in Sweden. The final ceremony for […]
SenzaGen AB is a diagnostic company working to replace animal testing for sensitization predictions. “Sensitization through the lung is a growing issue and methods to predict if a chemical has […]
PLoS One. 2015 Mar 11;10(3):e0118808. doi: 10.1371/journal.pone.0118808. eCollection 2015. Forreryd A., Johansson H., Albrekt AS, Borrebaeck CA, Lindstedt M. Abstract BACKGROUND: Repeated exposure to certain low molecular weight (LMW) chemical […]
SenzaGen continues its expansion and is setting up a sales and marketing organisation. In this process SenzaGen recruits Hanna Frykman as a marketing coordinator. Most recently, Hanna comes from the […]
